Literature DB >> 8851374

Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases.

S A Dunbar1, N P Katz.   

Abstract

A history of substance abuse is considered by many to be a contraindication to chronic opioid therapy for nonmalignant pain. Twenty patients with a history of chronic nonmalignant pain and substance abuse treated with chronic opioid therapy for a period of more than 1 year were retrospectively evaluated to determine the factors associated with prescription abuse. The prevalence of six aberrant behavioral patterns was assessed to see if these correlated with a history of prescription abuse, as reported by the patient's pain clinic physician. Those who did not abuse opioid therapy were more likely to have a history of alcohol abuse alone or a remote history of polysubstance abuse. They were also more likely to be active members of Alcoholics Anonymous and to have a stable family or other similar support system. In contrast, those who abused opioid therapy showed characteristic aberrant patterns of behavior in their management, which indicated a clear pattern of prescription abuse early in the course of therapy. Those patients were more likely to be recent polysubstance abusers, or have a prior history of oxycodone abuse. None of them were active members of Alcoholics Anonymous. Signing an "opioids contract" was not in and of itself a predictor of successful outcome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851374     DOI: 10.1016/0885-3924(95)00165-4

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  28 in total

Review 1.  Treating pain in patients with AIDS and a history of substance use.

Authors:  Yael Swica; William Breitbart
Journal:  West J Med       Date:  2002-01

2.  Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder.

Authors:  Benjamin J Morasco; Susan Gritzner; Lynsey Lewis; Robert Oldham; Dennis C Turk; Steven K Dobscha
Journal:  Pain       Date:  2010-12-23       Impact factor: 6.961

Review 3.  [Risk factors for substance abuse and dependence in opioid therapy for chronic noncancer-related pain].

Authors:  J Jage; A Willweber-Strumpf; C Maier
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

Review 4.  Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.

Authors:  Shannon M Smith; Florence Paillard; Andrew McKeown; Laurie B Burke; Robert R Edwards; Nathaniel P Katz; Elektra J Papadopoulos; Bob A Rappaport; Ashley Slagle; Eric C Strain; Ajay D Wasan; Dennis C Turk; Robert H Dworkin
Journal:  J Pain       Date:  2015-02-04       Impact factor: 5.820

5.  Aberrant drug-related behaviors: unsystematic documentation does not identify prescription drug use disorder.

Authors:  Ellen C Meltzer; Dennis Rybin; Lidia Z Meshesha; Richard Saitz; Jeffrey H Samet; Sonia L Rubens; Jane M Liebschutz
Journal:  Pain Med       Date:  2012-10-11       Impact factor: 3.750

Review 6.  Substance abuse issues in cancer pain.

Authors:  Laurie A Whitcomb; Kenneth L Kirsh; Steven D Passik
Journal:  Curr Pain Headache Rep       Date:  2002-06

Review 7.  Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention.

Authors:  V K Podichetty; D J Mazanec; R S Biscup
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

Review 8.  Effect of acute and chronic alcohol abuse on pain management in a trauma center.

Authors:  Shelley Wiechman Askay; Charles H Bombardier; David R Patterson
Journal:  Expert Rev Neurother       Date:  2009-02       Impact factor: 4.618

9.  Opioid therapy in patients with a history of substance abuse.

Authors:  Steven D Passik; Kenneth L Kirsh
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Challenges in using opioids to treat pain in persons with substance use disorders.

Authors:  Seddon R Savage; Kenneth L Kirsh; Steven D Passik
Journal:  Addict Sci Clin Pract       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.